candesartan has been researched along with deoxyguanosine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, H; Hiei, K; Kawasaki, H; Minatoguchi, S; Mizukusa, T; Ono, H; Takahashi, H; Tsukamoto, T; Uno, T; Watanabe, K; Yamada, Y | 1 |
| Hashimoto, T; Hirawa, N; Imai, N; Ishigami, T; Kihara, M; Kitamura, H; Kiuchi, Y; Nomura, K; Tamura, K; Toya, Y; Umemura, S; Yasuzaki, H; Yoshida, S | 1 |
| Akanae, W; Nonomura, N; Okuyama, A; Tsujihata, M; Yoshioka, I | 1 |
| Hayashi, T; Isaka, T; Iuchi, H; Kayama, Y; Sakamoto, M; Sakamoto, N; Suzuki, H; Tojo, K; Utsunomiya, K; Yoshimura, M | 1 |
| Miura, Y; Mizuno, K; Ono, Y; Takahashi, M; Watanabe, T | 1 |
| Amann, K; Brand, S; Mandel, P; Schupp, N; Zimnol, A | 1 |
1 trial(s) available for candesartan and deoxyguanosine
| Article | Year |
|---|---|
Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adiponectin; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; C-Reactive Protein; Deoxyguanosine; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Inflammation; Inflammation Mediators; Japan; Linear Models; Male; Middle Aged; Multivariate Analysis; Plasminogen Activator Inhibitor 1; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2012 |
5 other study(ies) available for candesartan and deoxyguanosine
| Article | Year |
|---|---|
Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carotid Arteries; Deoxyguanosine; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Tetrazoles; Tunica Intima; Tunica Media | 2008 |
Urinary oxidative stress markers closely reflect the efficacy of candesartan treatment for diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Deoxyguanosine; Diabetes Mellitus; Diabetic Nephropathies; Dinoprost; Disease Models, Animal; Hydralazine; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Tetrazoles; Treatment Outcome; Tyrosine | 2009 |
Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Calcium Oxalate; Deoxyguanosine; Disease Models, Animal; In Vitro Techniques; Kidney Calculi; Kidney Cortex; Male; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tetrazoles; Transforming Growth Factor beta | 2011 |
Suppression of advanced glycation and lipoxidation end products by angiotensin II type-1 receptor blocker candesartan in type 2 diabetic patients with essential hypertension.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Deoxyguanosine; Diabetes Mellitus, Type 2; Essential Hypertension; Female; Glycation End Products, Advanced; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Tetrazoles | 2013 |
Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Deoxyguanosine; DNA Damage; DNA Repair; Enzyme Activation; Eplerenone; Guanosine; Heart; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Spin Labels; Spironolactone; Tetrazoles | 2014 |